Olig2 Product List
You Have Viewed 0 Of 0 Results
Clinical Drug Information
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| IMAB-027 | ASP-1650; IMAB-027 | Phase 2 Clinical | Ganymed | Ovarian Neoplasms; Neoplasms; Neoplasms, Germ Cell and Embryonal | Details |
| TORL-1-23 | TORL-1-23 | Phase 2 Clinical | Torl Biotherapeutics LLC | Ovarian Neoplasms; Solid tumours; Carcinoma, Ovarian Epithelial; Fallopian Tube Neoplasms; Endometrial Neoplasms; Peritoneal Diseases; Carcinoma, Non-Small-Cell Lung | Details |
| BNT-142 | BNT-142 | Phase 2 Clinical | Biontech Se | Solid tumours | Details |
| CTIM-76 | CTIM-76 | Phase 1 Clinical | Integral Molecular Inc | Ovarian Neoplasms; Solid tumours; Neoplasms; Testicular Neoplasms; Endometrial Neoplasms | Details |
| NBL-028 | NBL028; NBL-028 | Phase 1 Clinical | Shanghai Xinshi Biological Medicine Co Ltd, Novarock Biotherapeutics Ltd | Solid tumours; Ovarian Neoplasms; Stomach Neoplasms; Neoplasms; Testicular Neoplasms; Endometrial Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
| XmAb-541 | XmAb541; XmAb-541 | Phase 1 Clinical | Xencor Inc | Ovarian Neoplasms; Ovarian germ cell tumor; Germinoma; Endometrial Neoplasms; Neoplasms, Germ Cell and Embryonal | Details |
| CLDN6-CAR-NK Cell Therapy | Phase 1 Clinical | Second Affiliated Hospital Of Guangzhou Medical University | Ovarian Neoplasms; Testicular Neoplasms; Endometrial Neoplasms | Details | |
| DS-9606a | DS-9606a; DS-9606-a | Phase 1 Clinical | Daiichi Sankyo Inc | Ovarian Neoplasms; Neoplasms; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal | Details |
| AMG-794 | AMG-794 | Phase 1 Clinical | Amgen Inc | Carcinoma, Ovarian Epithelial; Carcinoma, Non-Small-Cell Lung | Details |
| CLDN6 CAR-T cell therapy (BioNTech) | BNT-211 | Phase 1 Clinical | Biontech Se | Solid tumours | Details |